Key result
AngioVac aspiration system was successfully used for pulmonary embolectomy in a 22-year-old woman with Fontan circulation and saddle pulmonary embolism who failed thrombolytic therapy.
Case Report (n=1)
AngioVac aspiration is a viable treatment option for pulmonary embolism in complex patients with Fontan circulation who fail or have contraindications to thrombolytic therapy.
Answers are grounded in this paper and cite their sources.
Extends AngioVac feasibility to Fontan patients with saddle PE; leaves open safety and efficacy in larger cohorts.
Pulmonary embolism (PE) is a significant cause of morbidity and mortality among hospitalized patients, and thrombolytics are the mainstay of treatment. However, for patients who fail or have contraindications to thrombolytic therapy, catheter-based therapies, such as the AngioVac aspiration system, have emerged as an alternative to surgical embolectomy. Here, we present the novel case of a 22 year-old woman with Fontan circulation who developed severe postpartum cardiomyopathy and a saddle PE. She failed thrombolytic therapy but underwent successful pulmonary embolectomy by AngioVac aspiration. Patients with Fontan circulation have an increased incidence of thromboembolic events, and AngioVac thrombectomy is a valuable treatment option in these complex patients.
No takes yet. Share an insight, caveat, or question.
Török et al. (2015) conducted a case report in Saddle pulmonary embolism in Fontan circulation (n=1). AngioVac aspiration system was evaluated on Successful pulmonary embolectomy. AngioVac aspiration system was successfully used for pulmonary embolectomy in a 22-year-old woman with Fontan circulation and saddle pulmonary embolism who failed thrombolytic therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: